GlaxoSmithKline (GSK)

Sector: Pharma and Biotech     Index: FTSE 100
-1.02%
-15.00p
1,456.50p
10:40 04/05/16

   Spread betting | CFDs | Stockbroking   Trade now with IG Sponsored by IG. Losses can exceed deposits

1,456.50p
10:40 04/05/16
DAILY VARIATION
-1.02%
-15.00p
VOLUME
1,723,071
REAL TIME BATS
1,456.50p
10:40 04/05/16
-1.02%
-15.00p
DATA
52 Week High
1,514.50p
52 Week Low
1,237.50p
Shares Issued
4,871.49m
Market Cap
£70,953.28m
RiskGrade
88
Beta
0.89
MENU

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 5.4% 5.6%
Div Cover 0.9 1.1
Op Mrgn 43.1% 23.7%
ROCE 272.9%
Latest F'cast
P/E 19.4 16.5
PEG -0.9 1.0
Pr/Revenue 3.0 2.8
Pr/Book 8.1
Latest F'cast
Revenue 4.0% 1.8%
PBT 254.6% n/a
EPS -20.6% -6.0%
DPS 0.0% 1.2%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2011-12-31 27,387.00 7,698.00 114.10p 12.9 0.1 112% 70.00p 4.8%
2012-12-31 26,431.00 6,600.00 111.40p 12.0 -5.1 -2% 74.00p 5.5%
2013-12-31 26,505.00 6,647.00 108.40p 14.9 -5.5 -3% 78.00p 4.8%
2014-12-31 23,006.00 2,968.00 95.40p 14.4 -1.2 -12% 80.00p 5.8%
2015-12-31 23,923.00 10,526.00 75.70p 18.1 -0.9 -21% 80.00p 5.8%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 25,583.40 6,068.98 88.10p 16.5 1.0 16% 81.88p 5.6%
2017-12-31 26,417.88 6,345.40 91.89p 15.8 3.7 4% 79.95p 5.5%

Regulatory News

slide to see more
Director/PDMR Shareholding 03-May-16 14:37
Director/PDMR Shareholding 03-May-16 11:29
Total Voting Rights 03-May-16 11:22

Newspaper Links

No results found
No results found